# Tadalafil for the Treatment of Raynaud's

> **NCT00822354** · NA · COMPLETED · sponsor: **Northwestern University** · enrollment: 10 (actual)

## Conditions studied

- Raynaud

## Interventions

- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT00822354
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822354, "Tadalafil for the Treatment of Raynaud's". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00822354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*